The global healthcare contract development and manufacturing organization market size was USD 227.85 billion in 2023, calculated at USD 247.22 billion in 2024 and is expected to reach around USD 558.95 billion by 2034, expanding at a CAGR of 8.5% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Healthcare Contract Development and Manufacturing Organization Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Healthcare Contract Development and Manufacturing Organization Market, by Services Type, 2024-2034
8.1.1. Contract Manufacturing
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Contract Development
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. North America
9.1.1. Market Revenue and Forecast, by Services (2021-2034)
9.1.2. U.S.
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Forecast, by Services (2021-2034)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Services (2021-2034)
9.2.2. UK
9.2.2.1. Market Revenue and Forecast, by Services (2021-2034)
9.2.3. France
9.2.3.1. Market Revenue and Forecast, by Services (2021-2034)
9.2.4. Rest of Europe
9.2.4.1. Market Revenue and Forecast, by Services (2021-2034)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Services (2021-2034)
9.3.2. India
9.3.2.1. Market Revenue and Forecast, by Services (2021-2034)
9.3.3. China
9.3.3.1. Market Revenue and Forecast, by Services (2021-2034)
9.3.4. Japan
9.3.4.1. Market Revenue and Forecast, by Services (2021-2034)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Forecast, by Services (2021-2034)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Services (2021-2034)
9.4.2. GCC
9.4.2.1. Market Revenue and Forecast, by Services (2021-2034)
9.4.3. North Africa
9.4.3.1. Market Revenue and Forecast, by Services (2021-2034)
9.4.4. South Africa
9.4.4.1. Market Revenue and Forecast, by Services (2021-2034)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Forecast, by Services (2021-2034)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Services (2021-2034)
9.5.2. Brazil
9.5.2.1. Market Revenue and Forecast, by Services (2021-2034)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Forecast, by Services (2021-2034)
10.1. Flex
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Covance Inc.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Lonza Group Ltd.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Thermo Fisher Scientific Inc.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Jabil
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Catalent Inc.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Sanmina Corporation
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. IQVIA Holdings Inc.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample